Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.

Le Guevelou J, Zilli T, Ferrario F, Murthy V, Tree A, Loblaw A, Van der Heide UA, Kishan A, Draulans C, Martin J, Ost P, Sargos P.

Open source

DOI
10.1038/s41391-025-01071-7
Published
2025-12-23
Container
Prostate Cancer Prostatic Dis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41391-025-01071-7,
  title = {Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.},
  author = {Le Guevelou J and  Zilli T and  Ferrario F and  Murthy V and  Tree A and  Loblaw A and  Van der Heide UA and  Kishan A and  Draulans C and  Martin J and  Ost P and  Sargos P.},
  year = {2026},
  journal = {Prostate Cancer Prostatic Dis},
  doi = {10.1038/s41391-025-01071-7},
  url = {https://doi.org/10.1038/s41391-025-01071-7}
}

RIS

TY  - JOUR
TI  - Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.
AU  - Le Guevelou J
AU  -  Zilli T
AU  -  Ferrario F
AU  -  Murthy V
AU  -  Tree A
AU  -  Loblaw A
AU  -  Van der Heide UA
AU  -  Kishan A
AU  -  Draulans C
AU  -  Martin J
AU  -  Ost P
AU  -  Sargos P.
PY  - 2026
JO  - Prostate Cancer Prostatic Dis
DO  - 10.1038/s41391-025-01071-7
UR  - https://doi.org/10.1038/s41391-025-01071-7
ER  - 

APA

J, L. G., T, Z., F, F., V, M., A, T., A, L., UA, V. D. H., A, K., C, D., J, M., P, O., & P., S. (2026). Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-025-01071-7

Source records